For gene therapy researchers, I created communication assets demonstrating the Gyrolab® Anti-AAVX Kit’s superiority over slower, resource-intensive ELISA methods. These highlighted Gyrolab’s key advantages in speed, efficiency, and reliability, showing how it streamlines workflows and accelerates crucial anti-AAV testing to speed up therapy development.